ZNTL
ZentalisANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ZNTL vs peer average
93/100
ZNTL vs. peer average (A vs. D)
Grade spread
B 2 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AVXL is the first available peer comparator.
Loose event-risk comparator: another small-cap clinical biotech where trial timing and capital access dominate valuation; useful only as a volatility reference rather than a direct operating peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ZNTL
Zentalis
AVXL
Anavex Life Sciences
Grade
A
F
Momentum
94
4
Value
41
41
Sentiment
60
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AVXL
ZNTL / AVXL
Grade Position
Above peers
ZNTL vs. peer average (A vs. D)
93/100
Momentum
94
ZNTLValue
41
ZNTLSentiment
60
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ZNTL
AVXL is the first peer returned for this comparison set.